Arseny Kaprelyants Selected Research

2-thiopyridine

1/2014

New 2-thiopyridines as potential candidates for killing both actively growing and dormant Mycobacterium tuberculosis cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Arseny Kaprelyants Research Topics

Disease

6	Tuberculosis (Tuberculoses) 02/2021 - 12/2007
3	Infections 02/2021 - 12/2007
2	Hypoxia (Hypoxemia) 02/2021 - 02/2008
1	Latent Tuberculosis 01/2022
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2015
1	Hypersensitivity (Allergy) 02/2008
1	Starvation 02/2008
1	Persistent Infection 12/2007

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2007
2	AerosolsIBA 05/2011 - 12/2007
2	pimagedine (aminoguanidine)IBA 05/2011 - 12/2007
1	AntigensIBA 01/2022
1	ProdrugsIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 02/2021
1	IronIBA 02/2021
1	Virulence Factors (Pathogenicity Factors)IBA 02/2021
1	CopperIBA 01/2018
1	Isoniazid (Ftivazide)FDA LinkGeneric 01/2014
1	2-thiopyridineIBA 01/2014
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2014
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2014
1	Arachidonic Acid (Vitamin F)IBA 01/2013
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2013
1	VaccinesIBA 05/2011
1	Detergents (Detergent)IBA 02/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2007
1	AntibodiesIBA 12/2007
1	Muramidase (Lysozyme)IBA 12/2007
1	EnzymesIBA 12/2007

Therapy/Procedure

4	Resuscitation 01/2015 - 12/2007